expert panel - MGH Center for Women's Mental Health

Beyond the FDA Panel: Medical Experts Reaffirm the Safety and Essential Role of SSRIs for Perinatal Mental Health

The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; however, medical organizations and experts support the important role of SSRIs and other medications in supporting maternal mental health.

By Ruta Nonacs, MD PhD|2025-10-09T10:59:45-04:00October 9th, 2025|Medications and Pregnancy, Psychiatric Disorders During Pregnancy|Comments Off

Marlene Freeman, MD: Getting to the Truth About SSRIs and Pregnancy (Video)

The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; Dr. Freeman weighs in on the information provided in the report.

By MGH Center for Women's Mental Health|2025-08-18T13:33:02-04:00August 18th, 2025|Antidepressants, Medications and Pregnancy, Psychiatric Disorders During Pregnancy|Comments Off

Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy

The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.

By Ruta Nonacs, MD PhD|2025-10-09T10:59:51-04:00August 14th, 2025|Antidepressants, Medications and Pregnancy, Psychiatric Disorders During Pregnancy|Comments Off

Weighing the Evidence: Response to the FDA’s Recent Panel on Antidepressant Use in Pregnancy.

The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.

By Ruta Nonacs, MD PhD|2025-10-09T10:59:53-04:00July 23rd, 2025|Antidepressants, Psychiatric Disorders During Pregnancy|Comments Off